Related Experiment Video
Updated: Jun 3, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Rescue extracorporeal membrane oxygenation in children with refractory cardiac arrest
Eva Maria Delmo Walter1, Vladimir Alexi-Meskishvili, Michael Huebler
1Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany. delmo-walter@dhzb.de
Insights
Extracorporeal cardiopulmonary resuscitation (CPR) using extracorporeal membrane oxygenation (ECMO) can be a life-saving intervention for children with refractory cardiac arrest. Prolonged CPR and high-dose inotropes are key predictors of mortality in these pediatric patients.
Area of Science:
- Pediatric Critical Care Medicine
- Cardiovascular Surgery
- Extracorporeal Life Support
Background:
- Refractory cardiac arrest in children presents a significant therapeutic challenge.
- Extracorporeal membrane oxygenation (ECMO) offers a potential rescue therapy for refractory cardiac arrest.
- Limited data exists on predictors of mortality in pediatric patients undergoing extracorporeal CPR (ECPR).
Purpose of the Study:
- To describe the experience with extracorporeal CPR using ECMO in children with refractory cardiac arrest.
- To identify predictors of mortality in this pediatric population.
Main Methods:
- Retrospective review of 42 children who received ECMO for refractory cardiac arrest between 1992 and 2008.
- Data collected included patient demographics, diagnosis, cannulation site, CPR duration, and inotropic support.
- Statistical analysis to determine predictors of mortality.
Main Results:
- ECMO was initiated in 42 children (median age 0.7 years) with various underlying conditions including postcardiotomy, congenital heart disease, and trauma.
- Successful discontinuation of ECMO was achieved in 17 patients.
- Neurological injury was the primary cause of mortality.
- Pre-ECMO CPR duration (mean 35±1.3 min for survivors vs. 46±4.2 min for non-survivors) and high-dose inotropes were significant predictors of mortality.
- Age, weight, sex, diagnosis, and etiology were not significant predictors.
Conclusions:
- Rescue ECMO for pediatric refractory cardiac arrest can lead to acceptable survival and neurological outcomes.
- Prolonged CPR duration and the need for high-dose inotropes are critical indicators for poor prognosis.
- ECMO is a viable option for refractory cardiac arrest in children, but careful patient selection and management are crucial.
Abstract:
We describe our experience with extracorporeal cardiopulmonary resuscitation (CPR) using extracorporeal membrane oxygenation (ECMO) in children with refractory cardiac arrest, and determine predictors for mortality. ECMO support was instituted on 42 children, median age 0.7 years (1 day-17.8 years), median weight 7.05 (range 2.7-80) kg who suffered refractory cardiac arrest (1992-2008). Patients were postcardiotomy (n=27), or had uncorrected congenital heart diseases (n=3), cardiomyopathy (n=3), myocarditis (n=2), respiratory failure (n=3), or had trauma (n=4). Cannulation site was the chest in all except for three neonates who were cannulated through the neck vessels and two children who had femoral cannulation. ECMO was successfully discontinued in 17 patients. Primary cause of mortality was neurological injury. Pre-ECMO CPR duration for survivors against those who died was a mean of 35±1.3 min vs. a mean of 46±4.2 min. Age, weight, sex, anatomic diagnosis, etiology (surgical vs. medical) were not significant predictors of poor outcome. Prolonged CPR and high-dose inotropes are significant predictors of mortality. Rescue ECMO support in children with refractory cardiac arrest can achieve acceptable survival and neurological outcomes.
Related Concept Videos
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
